Heart drug showdown: which works better during bypass surgery?
NCT ID NCT05222256
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compared two medications, levosimendan and adrenaline, given during heart bypass surgery to patients with weak hearts (ejection fraction 30-40%). Sixty adults aged 18-65 having elective surgery were included. The goal was to see which drug better supports heart function during and after the operation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC HEART DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Assuit university
Asyut, Asyut Governorate, 11511, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a higher dose of adenosine sharpen heart scans?
- Dental repair may boost heart and metabolic health
- Heart attack aftermath: new imaging method may spot hidden danger zones better than standard tests
- New stent design tested in thousands with complex heart blockages
- Cooling helmet may shield brain from Post-Surgery mental decline
- AR video may ease anxiety before heart catheterization